GlassScriptPhysician profile
Casey Adams
NPI 1437540184
$7,796.00
in general payments reported to CMS, 2019-2025
46 companies · $1,239 in 2025
The $1,239 reported for 2025 was more than what 88% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,407 · 2022: $1,837 · 2023: $1,615 · 2024: $1,698 · 2025: $1,239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,552.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $942.66 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $915.79 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $782.85 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $555.99 | 2021-2025 | Repatha, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $484.20 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $453.45 | 2021-2025 | Ubrelvy, Vraylar, Qulipta |
| Novartis Pharmaceuticals Corporation | $407.78 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $321.94 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $319.69 | 2023-2025 | Gemtesa |
| Pfizer INC. | $319.16 | 2021-2025 | |
| Abbott Laboratories | $285.32 | 2022-2025 | Freestyle Libre, Cardiomems |
| Boehringer Ingelheim Pharmaceuticals, INC. | $213.46 | 2021-2024 | Jardiance, Ofev |
| Merck Sharp & Dohme LLC | $213.16 | 2021-2025 | Capvaxive, Gardasil 9, Winrevair |
| Astellas Pharma US INC | $172.88 | 2021-2025 | Veozah |
| Grt US Holding, INC. | $132.99 | 2021-2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.